| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | 0.001 | 1 |
| mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00079 | 1 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.00072 | 1 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | 0.00062 | 1 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.00069 | 1 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | -0.00068 | 1 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | 0.00072 | 1 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | 0.00043 | 1 |